يعرض 681 - 700 نتائج من 19,656 نتيجة بحث عن '(( significant ((a decrease) OR (linear decrease)) ) OR ( significantly increased decrease ))', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 681
  2. 682

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  3. 683

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  4. 684

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  5. 685
  6. 686
  7. 687
  8. 688
  9. 689
  10. 690

    Fig 10 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  11. 691

    Fig 4 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  12. 692

    Fig 9 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  13. 693

    Fig 6 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  14. 694

    Fig 7 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  15. 695

    Fig 8 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  16. 696

    A representative ultrasound axis image. حسب Eun-Seon Yang (19751340)

    منشور في 2024
    الموضوعات:
  17. 697
  18. 698
  19. 699
  20. 700